Publications:
A selected list of publications:
Yu Elmer, Miotto Karen, Akerele Evaristo, Montgomery Ann, Elkashef Ahmed, Walsh Robert, Montoya Ivan, Fischman Marian W, Collins Joseph, McSherry Frances, Boardman Kathy, Davies David K, O'Brien Charles P, Ling Walter, Kleber Herbert, Herman Barbara H
A Phase 3 placebo-controlled, double-blind, multi-site trial of the
alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal
Drug and alcohol dependence,
2008; 97(1-2):
158-68.
Yu Elmer, Miotto Karen, Akerele Evaristo, O'Brien Charles P, Ling Walter, Kleber Herbert, Fischman Marian W, Elkashef Ahmed, Herman Barbara H, Al-Ghananeem Abeer M
Clinical pharmacokinetics of lofexidine, the alpha 2-adrenergic
receptor agonist, in opiate addicts plasma using a highly sensitive
liquid chromatography tandem mass spectrometric analysis
The American journal of drug and alcohol abuse,
2008; 34(5):
611-6.
London Edythe D, Simon Sara L, Berman Steven M, Mandelkern Mark A, Lichtman Aaron M, Bramen Jennifer, Shinn Ann K, Miotto Karen, Learn Jennifer, Dong Yun, Matochik John A, Kurian Varughese, Newton Thomas, Woods Roger, Rawson Richard, Ling Walter
Mood disturbances and regional cerebral metabolic abnormalities in
recently abstinent methamphetamine abusers
Archives of general psychiatry,
2004; 61(1):
73-84.
Miotto Karen, McCann Michael, Basch Janice, Rawson Richard, Ling Walter
Naltrexone and dysphoria: fact or myth?
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions,
2002; 11(2):
151-60.